Basics IDEAYA Biosciences, Inc. IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.56B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.92% Avg Daily Range (30 D): $0.48 | 1.78% Avg Daily Range (90 D): $0.50 | 2.02% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): 1.1M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 2,497 Avg Inst. Trade: $2.37M Avg Inst. Trade (30 D): $2.36M Avg Inst. Trade (90 D): $2.21M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.1M Avg Closing Trade (30 D): $4.8M Avg Closing Trade (90 D): $4.03M Avg Closing Volume: 119.65K     News Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor Jul 9, 2024 @ 12:31 PM Company News for July 9, 2024 - July 9, 2024 - Zac... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.84 $-.88 $-.82 Diluted EPS $-3.84 $-.88 $-.82 Revenue $ 7M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -331.8M $ -77.49M $ -72.18M Operating Income / Loss $ -384.23M $ -88.81M $ -84.39M Cost of Revenue $ $ $ Net Cash Flow $ -68.51M $ -15.35M $ 45.62M PE Ratio